Avenue Therapeutics, Inc.
ATXI
$0.794
$0.0212.72%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -47.20% | 54.01% | 79.14% | 1,007.45% | -89.75% |
Total Receivables | -- | -- | -- | -- | -50.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -59.42% | -40.52% | 73.13% | 272.22% | -73.91% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -47.37% | 50.69% | 78.92% | 268.53% | -69.87% |
|
|||||
Total Current Assets | -47.37% | 50.69% | 78.92% | 268.53% | -69.87% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -47.37% | 50.69% | 78.92% | 268.53% | -69.87% |
|
|||||
Total Accounts Payable | 10.98% | -10.57% | 65.09% | -28.39% | 12.00% |
Total Accrued Expenses | -45.02% | 54.90% | 61.24% | -82.04% | -19.17% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -38.30% | -88.62% | -29.52% | -82.24% | -43.80% |
Total Other Current Liabilities | -38.30% | -88.62% | -29.52% | -82.24% | -43.80% |
Total Current Liabilities | -16.19% | -17.78% | 18.06% | -76.19% | -35.69% |
|
|||||
Total Current Liabilities | -16.19% | -17.78% | 18.06% | -76.19% | -35.69% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -16.19% | -17.78% | 18.06% | -76.19% | -35.69% |
|
|||||
Common Stock & APIC | 0.90% | 4.71% | 6.05% | 5.22% | 1.34% |
Retained Earnings | -3.14% | -2.83% | -4.77% | 0.70% | 0.57% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -45.21% | 67.98% | 79.27% | 143.34% | 31.60% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -45.21% | 67.98% | 79.27% | 143.34% | 31.60% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -2.24% | 0.11% | -1.08% | -6.42% | -7.65% |
Total Equity | -56.83% | 101.63% | 190.21% | 114.46% | 26.42% |
|